Rede D’Or invested R$ 100 million in 5 years in the oncology area and offers resources that allow the care of cases previously considered inoperable
Advances and investments in new technologies have changed the direction of cancer treatment in Brazil, with techniques and equipment that contribute to ensuring new perspectives in combating the disease. In the last 5 years, for example, the D’Or Network made an investment of R$100 million in more precise equipment, helping the company’s oncology sector to treat types of cancer that were previously inoperable in Brazil.
The contribution to D’Or Oncology reflects the current capillarity of the network in the country. There are 55 oncology clinics distributed across 10 states and the Federal District. Furthermore, Rede D’Or has an advanced radiotherapy park and performs, on average, 55 thousand radiotherapy treatments per year. Most patients with the disease need this type of resource, which uses ionizing radiation to destroy or prevent the growth of cancer cells, and modern equipment increases the efficiency of treatment.
On the list of new devices in the country are the CyberKnifewhich has a robotic arm to apply radiotherapy with greater accuracy, and the TomoTherapywhich uses images to detect the position of the tumor and target cancer cells precisely.
The machines at the Oncologia D’Or radiotherapy park synchronize respiratory movements, follow the lesion in real time and emit very high doses of radiation with submillimetre precision into the tumor, sparing the surrounding healthy tissues – which makes all the difference in preventing the effects adverse effects caused by radiotherapy.
“The survival rate of cancer patients has increased significantly in recent years and, with the advancement of technologies and precision medicine, cancer is an increasingly treatable disease. To achieve this, it is essential to have all the information to indicate the most personalized, safe and effective treatment for each patient, and the structure we have at Rede D’Or allows this to be done.”, stated the president of Oncologia D’Or, Paulo Hoff.
The president of Oncologia D’Or, Paulo Hoff, highlights that Rede D’Or’s oncological care follows the quality standard present throughout the country
Read the infographic about Oncologia D’Or’s exclusive equipment.
Equipment technology also provides a significant reduction in treatment time. With so-called ultrahypofractionated radiotherapy, higher doses are applied at very short intervals, which can be irradiated safely thanks to the precision of the technology. In cases of prostate cancer, for example, CyberKnife made progress possible by reducing radiotherapy sessions for treatment, carried out on consecutive days, from 39 to 5.
“This way, it is possible to reduce treatment time and possible adverse effects. In another example, in breast cancer, patients who needed 25 to 30 radiotherapy sessions are now treated with 15 sessions”, said radio-oncologist Elisângela Santos Carvalho, medical coordinator of radiotherapy at Rede D’Or in Bahia.
Integration and shared expertise
Oncologia D’Or’s clinics are integrated into the group’s 73 hospitals. Oncology care units are present in São Paulo, Rio de Janeiro, Ceará, Maranhão, Paraíba, Pernambuco, Bahia, Sergipe, Alagoas, Paraná and the Federal District. According to the network, every month, more than 10 thousand people seek care at Oncologia D’Or, considering that the same patient can be seen more than once.
“Thanks to the national coverage of Rede D’Or, access to the most up-to-date protocols and treatments is within the reach of more patients. This enables the same quality of care in any of our units”, stated Paulo Hoff.
Among Oncologia D’Or’s differentials, in addition to the integration of network units and exclusive equipment technologies in the country, are the medical teams led by internationally renowned specialists in their fields. The cancer patient is monitored by the same team from diagnosis to treatment, which may include surgery, radiotherapy and the use of medications, among others.
“Exams, consultations, hospitalizations. The patient goes through all stages of their journey within our hospitals and clinics, with the support of specialists who make decisions together”, said the medical director of DF Star Hospital, from Brasília, Allisson Borges.
Read the infographic about Oncologia D’Or’s service network.
The coordinator of the radiotherapy service at Rede D’Or, Karina Moutinho, explains that an integrated system of images and medical records facilitates the clinical discussion of more complex cases. “We are able to offer the best in an individualized response to the disease, which increases the recovery rates of our patients”, said the doctor.
![](https://static.poder360.com.br/2023/10/fachada2.jpg)
Vila Nova Star, in São Paulo (SP), is one of the Rede D’Or hospitals that has radiotherapy equipment
With the integration and work together, the medical physicist and radiotherapy manager at Oncologia D’Or, Renan Serrano, highlights that patients treated in the network have the benefit of counting on the availability of modern radiotherapy centers, even if they are from other cities. “With the support of reputable professionals and the high-performance technologies we provide, patients receive the same treatment offered in the best cancer centers in the United States and Europe”, he stated.
Research optimizes treatments
In addition to offering a broad service network with high quality standards, Oncologia D’Or and Rede D’Or play an active role in changing paradigms in cancer treatment, investing in research, technology and innovation. Recently, with an investment of R$80 million, the network opened a reference molecular pathology laboratory in Latin America, with unprecedented tests for rapid diagnosis and personalized treatment of cancer patients.
“Molecular genomics combined with innovations in digital health, image analysis and data science are revolutionizing healthcare. By investing in new technologies, Rede D’Or boosts precision oncology in Latin America”, said the teacher and chair of Pathology and Laboratory Medicine at Perelman School of Medicine, in the United States, George Netto.
Together with Idor (Institute D’Or for Research and Teaching), the network focuses on clinical research with new medicines and therapeutic possibilities, with an emphasis on the oncology area. The research partnership already allows the use of AI (artificial intelligence) in X-rays to diagnose lung cancer.
With the support of Idor researchers, the Rede D’Or radiology team put this tool into practice, which re-reads radiological reports and supports the specialist in detecting pulmonary nodules.
“The large volume of cancer patients, captured in our hospitals and clinics in 10 states and the Federal District, is an opportunity to lead work that can change the treatment and clinical outcome of these patients”, said the radio-oncologist at Oncologia D’Or in Rio de Janeiro and researcher at Idor, Pedro Pinho.
This one content was produced and paid for by D’Or Network.
#DOr #Oncology #national #reference #cancer #treatment